J. Bates

发表

Proof of principle for epitope-focused vaccine design

David Baker, Eric Stevens, Man Chen, 2014, Nature.

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.

A. Osterhaus, J. Bates, G. Rimmelzwaan, 2000, Vaccine.

Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus

R. Linhardt, J. Bates, Fuming Zhang, 2021, Carbohydrate Polymers.

De novo protein design enables precise induction of functional antibodies in vivo

B. Correia, P. Corthésy, J. Bates, 2020 .

Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from Monostroma nitidum

C. Chen, J. Bates, J. Dordick, 2021, Marine drugs.

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model

O. Bohorov, N. Bohorova, M. Pauly, 2013, mAbs.

Enhanced responsiveness to antigen contributes more to immunological memory in CD4 T cells than increases in the number of cells

J. Bates, R. Pat Bucy, 2005, Immunology.

Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate

J. Bates, J. Dordick, Fuming Zhang, 2022, Pharmaceuticals.

Flagellin as an Adjuvant: Cellular Mechanisms and Potential

J. Bates, S. Mizel, 2010, The Journal of Immunology.

Mucosal adjuvant activity of flagellin in aged mice

J. Bates, S. Mizel, N. Kock, 2008, Mechanisms of Ageing and Development.

Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK).

J. Oxford, R. Webster, J. Bates, 1987, Bulletin of the World Health Organization.

Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use.

J. Bates, L. Brown, D. Jackson, 1998, Vaccine.

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

J. Bates, D. Drane, A. Coulter, 1998, Vaccine.

Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice.

J. Bates, C. S. Swindle, C. Cotta, 2007, Blood.

Flagellin Necessary for the Adjuvant Activity of Cells Is + CD 11 c + / + tlr 5 Direct Stimulation of Mizel

S. Akira, J. Bates, S. Uematsu, 2009 .

IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity

G. Marshall, J. Bates, S. Lirette, 2022, Vaccines.

Tegument Protein pp150 Sequence-Specific Peptide Blocks Cytomegalovirus Infection

Mohammad H. Hasan, J. Bates, G. Bidwell, 2021, Viruses.

Efficacy of POC Antibody Assays after COVID-19 Infection and Potential Utility for “Immunity Passports”

J. Bates, P. Kyle, H. Laharwani, 2021, Laboratory medicine.

Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein

J. Bates, S. Stray, Poonam Sharma, 2020, Scientific Reports.

Development of an Influenza-Iscom™ Vaccine

J. Bates, D. Drane, A. Coulter, 1997 .

Direct Stimulation of tlr5+/+ CD11c+ Cells Is Necessary for the Adjuvant Activity of Flagellin1

John T. Bates, Shizuo Akira, S. Akira, 2009, The Journal of Immunology.

Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.

Daniel W. Kulp, J. Crowe, W. Schief, 2014, Virology.

STAT4 Deficiency Fails To Induce Lung Th2 or Th17 Immunity following Primary or Secondary Respiratory Syncytial Virus (RSV) Challenge but Enhances the Lung RSV-Specific CD8+ T Cell Immune Response to Secondary Challenge

J. Crowe, J. Bates, K. Boyd, 2014, Journal of Virology.

Reversion of Somatic Mutations of the Respiratory Syncytial Virus–Specific Human Monoclonal Antibody Fab19 Reveal a Direct Relationship between Association Rate and Neutralizing Potency

J. Crowe, W. Schief, B. Correia, 2013, The Journal of Immunology.

Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus

J. Mumford, J. Bates, 1984, Veterinary Record.

Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.

J. Bates, Xiangdong Li, W. Feng, 2015, Vaccine.

Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots

S. S. Sinha, J. Bates, A. Pramanik, 2022, ACS omega.

Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections.

S. S. Sinha, J. Bates, R. Seshadri, 2022, ACS applied bio materials.

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein

J. Meiler, J. Crowe, W. Schief, 2016, Proceedings of the National Academy of Sciences.

Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.

R. Johnston, J. Crowe, J. Bates, 2016, Vaccine.

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants

J. Bates, J. Dordick, Fuming Zhang, 2022, Frontiers in Molecular Biosciences.

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus

R. Lamb, J. Crowe, J. Bates, 2017, Nature Microbiology.

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Luciano A. Abriata, John T. Bates, Bruno E. Correia, 2020, Science.

Enhanced Antigen Processing of Flagellin Fusion Proteins Promotes the Antigen-Specific CD8+ T Cell Response Independently of TLR5 and MyD88

J. Bates, S. Mizel, J. Grayson, 2011, The Journal of Immunology.

Naïve CD4+ T Cell Activation in the Nasal-Associated Lymphoid Tissue following Intranasal Immunization with a Flagellin-Based Subunit Vaccine

J. Bates, 2022, International journal of molecular sciences.

Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.

Daniel W. Kulp, J. Crowe, W. Schief, 2014, Virology.

Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin

J. Bates, J. Dordick, Ke Xia, 2024, Viruses.